腹痛：勿忘钍造影剂！
Abdominal pain: do not forget Thorotrast!
作者信息
Weber E, Laarbaui F, Michel L, Donckier J
机构信息
Division of Internal Medicine and Endocrinology, University Hospital of Mont-Godinne, Yvoir, Belgium.
出版信息
Postgrad Med J. 1995 Jun;71(836):367-8. doi: 10.1136/pgmj.71.836.367.
Abstract
The use of Thorotrast (25% thorium dioxide), a radiologic contrast agent used up until the mid-1950s, was associated with a wide range of malignancies, mainly of hepatic origin. We report a case of Thorotrast-induced hepatocarcinoma in an 82-year-old woman.
摘要
钍造影剂（二氧化钍含量25%）一直使用到20世纪50年代中期，其使用与多种恶性肿瘤相关，主要起源于肝脏。我们报告一例82岁女性因钍造影剂诱发肝癌的病例。
Zotero 插件